Endometrial Hyperplasia

This is when the lining of your uterus, called the endometrium, grows too thick. It's not cancer, but it can increase your risk of developing uterine cancer later. Doctors classify it based on how abnormal the cells look under a microscope.

Condition

What people with Endometrial Hyperplasia report

Every report comes from a Lived member, sent anonymously.

Have you had Medicated IUDs for Endometrial Hyperplasia?

NameHow it went

About Endometrial Hyperplasia

What It Is

Endometrial hyperplasia means the endometrium, the lining of the uterus, has grown too thick. It is not cancer, but some forms can lead to uterine cancer, which is why it is taken seriously. Its most common sign is abnormal bleeding: periods that are heavier, longer or more frequent than usual, or any bleeding after menopause. What matters most is the type, which a pathologist determines by looking at the cells under a microscope. Hyperplasia without atypia means the lining is overgrown but the cells look normal; it rarely turns into cancer and usually reverses with hormone treatment. Atypical hyperplasia, also called endometrial intraepithelial neoplasia (EIN), means the cells themselves look abnormal. It is considered precancerous, and cancer is sometimes already present alongside it. Older terms such as simple and complex hyperplasia appear in some reports and generally fall under the without-atypia group unless atypia is mentioned.

Causes & Risk Factors

The lining of the uterus thickens in response to estrogen each month. After ovulation, the hormone progesterone stabilizes it, and when progesterone falls the lining sheds as a period. Endometrial hyperplasia most often develops when the lining is exposed to estrogen without enough progesterone to balance it, so it keeps growing instead of shedding. That imbalance is common in perimenopause and after menopause, when ovulation becomes irregular or stops. It also occurs with polycystic ovary syndrome (PCOS) and other causes of irregular cycles, with obesity (fat tissue makes estrogen), with estrogen-only hormone therapy in someone who still has a uterus, and with tamoxifen, a breast cancer medicine that acts like estrogen on the uterus. This is why people with a uterus who take estrogen after menopause are prescribed a progestin or progesterone alongside it. Other associated factors include diabetes, never having been pregnant, a late menopause and a family history of uterine, ovarian or colon cancer. These raise the likelihood but do not mean any one factor caused it.

How It's Diagnosed

Evaluation usually starts because of abnormal bleeding. Many things cause abnormal bleeding, so testing is typically recommended for people 35 or older, after menopause, or when bleeding has not improved with treatment. A transvaginal ultrasound, in which a small probe placed in the vagina images the uterus, measures how thick the lining is. A thick lining raises suspicion but cannot tell hyperplasia from cancer. The diagnosis requires a tissue sample examined under a microscope, taken by an endometrial biopsy in the office, a dilation and curettage (D&C), or hysteroscopy, in which a thin lighted scope lets the clinician see inside the uterus and sample specific areas. The pathology report will say whether atypia is present, and that distinction guides treatment. Because atypical hyperplasia and early cancer can be hard to tell apart on a small sample, a more complete sampling is sometimes advised before choosing a treatment that keeps the uterus.

Treatment Options

For hyperplasia without atypia, the usual treatment is a progestin, a lab-made form of progesterone that counteracts estrogen's effect and lets the lining return to normal. It can be taken as pills, given as a shot, or delivered by a hormonal intrauterine device (IUD) that releases levonorgestrel, such as Mirena. Studies suggest the IUD reverses hyperplasia more often than pills over the first several months, and it avoids remembering a daily dose; the trade-off is more irregular bleeding or spotting. Progestins can cause period-like bleeding, and treatment usually lasts several months before a repeat biopsy. Addressing the cause matters too, such as adding a progestin to estrogen therapy or managing weight and blood sugar. Atypical hyperplasia is treated more aggressively because of its cancer risk. Hysterectomy, surgery to remove the uterus, is the definitive treatment and is generally recommended for people who do not plan a future pregnancy. For those who want to preserve fertility or cannot have surgery, high-dose progestin therapy (often by IUD, sometimes with pills) is an option, but it requires close follow-up with repeat biopsies to confirm the hyperplasia has resolved and has not progressed.

What to Expect

Hyperplasia without atypia usually responds well to treatment. The main tasks are completing the course, returning for a follow-up biopsy and correcting whatever led to the estrogen imbalance, since it can come back if the underlying cause persists. Over long follow-up, very few people with this type develop cancer; one large study found the risk was under 5% over 20 years. Atypical hyperplasia involves more decisions and closer monitoring. In studies, cancer was found at the time of surgery in roughly a third of people diagnosed with atypical hyperplasia, which is one reason surgery is the standard. For those who choose hormone treatment to preserve fertility, it often works, but it means repeat biopsies every few months, and the hyperplasia can persist or return. Many clinicians recommend hysterectomy once childbearing is complete. Bleeding patterns during treatment, especially with an IUD, may be irregular for some months.

When to Seek Help

See a gynecologist about any bleeding after menopause, even light spotting, and about periods that become heavier or longer than usual, come more often than every 21 days, or bleed between cycles. If you take estrogen without a progestin and still have a uterus, or take tamoxifen, discuss whether your lining needs monitoring. During treatment, contact your care team if bleeding becomes much heavier than expected, if new bleeding starts after it had settled, or if you miss a scheduled follow-up biopsy, since follow-up is what confirms the treatment worked.

Questions to Ask Your Doctor

  1. 1.Does my biopsy show atypia, and what does that mean for my risk of cancer?
  2. 2.Was enough tissue sampled to be confident cancer is not already present?
  3. 3.What are the pros and cons of a hormonal IUD, pills or surgery in my situation, including if I want to have children?
  4. 4.How often will I need follow-up biopsies, and what results would change the plan?
  5. 5.What caused the estrogen imbalance in my case, and what can I do to lower the chance it returns?

Last reviewed • Oct 2026

Educational content, not medical advice.